Progress in RA genetics, pathology and therapy
- 8 January 2013
- journal article
- review article
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 9 (2) , 70-72
Abstract
Developments in our knowledge of the aetiology and pathogenesis of rheumatoid arthritis continued apace in 2012, and several important new advances were reported in the therapy of this disease. Culminating in the approval of a new therapy in the USA, the year offered new insights for clinicians and fresh hope for patients.Keywords
This publication has 10 references indexed in Scilit:
- Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trialAnnals of the Rheumatic Diseases, 2013
- Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: A long‐term followup from disease onsetArthritis Care & Research, 2012
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid ArthritisNew England Journal of Medicine, 2012
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid ArthritisNew England Journal of Medicine, 2012
- Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritisArthritis Research & Therapy, 2012
- Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentinJournal of Clinical Investigation, 2012
- Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trialThe Lancet, 2012
- Effect of body mass index on mortality and clinical status in rheumatoid arthritisArthritis Care & Research, 2012
- A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trialArthritis & Rheumatism, 2012
- Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritisNature Genetics, 2012